Crossmark

Vitamin E-valproate co-therapy attenuated oxidative stress, neuroinflammation, related cognitive deficits and neuronal damage in Cypermethrin exacerbated seizure

Crossref DOI link: https://doi.org/10.1186/s40360-025-01027-6

Published Online: 2025-11-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Imam, Aminu

Tunde, Abdulraheem Mudathir

Amin, Abdulbasit

Abdulmajeed, Wahab Imam

Attai, Alhassan Godwin

Akorede, Aalimah Akinosho

Ijomone, Omamuyovwi Meashack

Ajao, Moyosore Salihu
License Information

Text and Data Mining valid from 2025-11-05

Version of Record valid from 2025-11-05
More Information

Article History

Received: 22 December 2024

Accepted: 15 October 2025

First Online: 5 November 2025

Declarations

:

: This research was approved by the University of Ilorin ethical review committee (UERC) (UIL/UERC/21/68LD001) in September 2024, following the recommendation of the College of Health Sciences ethical review committee, in compliance with the Institutional Animal Care and Use Committee (IACUC).

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below